THE MCMANUS GROUP for ALLERGAN INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare payment for inpatient antibiotics.
Foreign entity interest: 100% ownership by Allergan plc, Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BARRETT THORNHILL | — |
Health Issues HCR
FDA approval and enforcement issues. Support for Sec. 604 (B)(b) of H.R. 2430 - FDA Reauthorization Act of 2017. Advocated to include market incentives for antimicrobials in H.R. 2430 / S. 934 - FDA Reauthorization Act of 2017.
Foreign entity interest: 100% ownership by Allergan plc, Clonshaugh Business and Technology Park, Coolock, Dublin, D17 E400, Ireland.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.